Chronic Kidney Disease Interplay with Comorbidities and Carbohydrate Metabolism: A Review

被引:0
作者
Kushwaha, Radha [1 ]
Vardhan, Pothabathula Seshu [2 ]
Kushwaha, Prem Prakash [3 ]
Georgianos, Panagiotis
机构
[1] Univ Allahabad, Ctr Food Technol, Allahabad 211002, Uttar Pradesh, India
[2] Sardar Vallabhbhai Natl Inst Technol SVNIT, Dept Chem, Surat 395007, Gujarat, India
[3] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA
来源
LIFE-BASEL | 2024年 / 14卷 / 01期
关键词
chronic kidney disease; cellular growth homeostasis; inflammation; insulin resistance; dietary interventions; CHRONIC-RENAL-FAILURE; CLINICAL-PRACTICE GUIDELINES; BLOOD-PRESSURE VARIABILITY; OXIDATIVE STRESS; GROWTH-HORMONE; COGNITIVE IMPAIRMENT; ALL-CAUSE; CARDIOVASCULAR MORTALITY; INTERNATIONAL SOCIETY; HEMODIALYSIS-PATIENTS;
D O I
10.3390/life14010013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chronic kidney disease (CKD) poses a global health challenge, engendering various physiological and metabolic shifts that significantly impact health and escalate the susceptibility to severe illnesses. This comprehensive review delves into the intricate complexities of CKD, scrutinizing its influence on cellular growth homeostasis, hormonal equilibrium, wasting, malnutrition, and its interconnectedness with inflammation, oxidative stress, and cardiovascular diseases. Exploring the genetic, birth-related, and comorbidity factors associated with CKD, alongside considerations of metabolic disturbances, anemia, and malnutrition, the review elucidates how CKD orchestrates cellular growth control. A pivotal focus lies on the nexus between CKD and insulin resistance, where debates persist regarding its chronological relationship with impaired kidney function. The prevalence of insulin abnormalities in CKD is emphasized, contributing to glucose intolerance and raising questions about its role as a precursor or consequence. Moreover, the review sheds light on disruptions in the growth hormone and insulin-like growth factor axis in CKD, underscoring the heightened vulnerability to illness and mortality in cases of severe growth retardation. Wasting, a prevalent concern affecting up to 75% of end-stage renal disease (ESRD) patients, is analyzed, elucidating the manifestations of cachexia and its impact on appetite, energy expenditure, and protein reserves. Taste disturbances in CKD, affecting sour, umami, and salty tastes, are explored for their implications on food palatability and nutritional status. Independent of age and gender, these taste alterations have the potential to sway dietary choices, further complicating the management of CKD. The intricate interplay between CKD, inflammation, oxidative stress, and cardiovascular diseases is unraveled, emphasizing the profound repercussions on overall health. Additionally, the review extends its analysis to CKD's broader impact on cognitive function, emotional well-being, taste perception, and endothelial dysfunction. Concluding with an emphasis on dietary interventions as crucial components in CKD management, this comprehensive review navigates the multifaceted dimensions of CKD, providing a nuanced understanding essential for developing targeted therapeutic strategies.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Phosphorus metabolism in chronic kidney disease
    Fourtounas, C.
    HIPPOKRATIA, 2011, 15 : 50 - 52
  • [42] Mineral metabolism in chronic kidney disease
    Kochanek, Malgorzata
    Said, Albara
    Lerma, Edgar V.
    DM DISEASE-A-MONTH, 2015, 61 (10): : 425 - 433
  • [43] Chronic kidney disease and bone metabolism
    Kazama, Junichiro James
    Matsuo, Koji
    Iwasaki, Yoshiko
    Fukagawa, Masafumi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2015, 33 (03) : 245 - 252
  • [44] Neurological complications in chronic kidney disease patients
    Chillon, Jean-Marc
    Massy, Ziad A.
    Stengel, Benedicte
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (10) : 1606 - 1614
  • [45] Platelet - derived CD154 antigen in patients with chronic kidney disease
    Stepniewska, Joanna
    Dolegowska, Barbara
    Chrusciana, Marta
    Golembiewska, Edyta
    Malinowska-Jedraszczyk, Alicja
    Marchelek-Mysliwiec, Malgorzata
    Ciechanowski, Kazimierz
    CLINICAL BIOCHEMISTRY, 2016, 49 (03) : 243 - 247
  • [46] Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review
    Nakashima, Akio
    Kato, Kazuhiko
    Ohkido, Ichiro
    Yokoo, Takashi
    NUTRIENTS, 2021, 13 (12)
  • [47] Update of the mechanism and characteristics of tuberculosis in chronic kidney disease Review article
    Zhang, Xuehan
    Chen, Pingshan
    Xu, Gaosi
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (13-14) : 501 - 510
  • [48] Managing comorbidities in chronic kidney disease reduces utilization and costs
    Li, Yong
    Barve, Kanchan
    Cockrell, Meghan
    Agarwal, Amal
    Casebeer, Adrianne
    Dixon, Suzanne W.
    Poonawalla, Insiya
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [49] Insulin resistance in chronic kidney disease: new lessons from experimental models
    Koppe, Laetitia
    Pelletier, Caroline C.
    Alix, Pascaline M.
    Kalbacher, Emilie
    Fouque, Denis
    Soulage, Christophe O.
    Guebre-Egziabher, Fitsum
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (09) : 1666 - 1674
  • [50] Feline Comorbidities: Balancing hyperthyroidism and concurrent chronic kidney disease
    Geddes, Rebecca
    Aguiar, Joana
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (07) : 641 - 650